Skip to main content

Table 4 Multivariate Cox regression analysis of disease-free survival (patients with adenocarcinoma)

From: Reappraising the clinical usability of consolidation-to-tumor ratio on CT in clinical stage IA lung cancer

Variable

Crude HR (95% CI)

Adjusted HR (95% CI)

Sex (male)

2.07 (1.29–3.33)

1.94 (1.17–3.21)

Age

1.03 (1.00–1.06)

1.01 (1.01–1.06)

Surgery type

Limited resection*

1 (Ref.)

1 (Ref.)

Lobectomy

1.59 (0.85–2.96)

0.67 (0.33–1.36)

Pathologic invasive size

1.89 (1.49–2.42)

1.31 (0.96–1.78)

Pathologic nodal upstaging

6.84 (4.20–11.14)

3.69 (2.12–6.40)

Predominant histologic pattern

1.99 (1.17–3.38)

0.79 (0.44–1.44)

CTR

CTR < 75%

1 (Ref.)

1 (Ref.)

75% < CTR < 100%

5.59 (2.20–14.17)

5.36 (1.95–14.77)

CTR = 100%

11.01 (4.71–25.72)

6.93 (2.65–18.17)

  1. Adjusted for sex, age, surgery type, clinical T stage, histologic type, pathologic nodal upstaging, predominant histologic pattern for all subjects
  2. HR hazard ratio; CI confidence interval; ADC adenocarcinoma; and CTR: consolidation-to-tumor ratio
  3. *Limited resection = wedge resection + segmentectomy